Skip to content

Single Ascending Dose study of ENX-104

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514265-19-00
Acronym
ENX-104-001
Enrollment
48
Registered
2024-07-16
Start date
2024-07-17
Completion date
2025-04-03
Last updated
2024-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

None listed

Sponsors

Engrail Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026